Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Earl

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Kidney International Reports|May 4, 2021
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against ReinfectionLuke Muir, Aneesa Jaffer, Chloe Rees-Spear, et al.
Nature Communications|October 6, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Research Square|March 24, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Science (New York, N.Y.)|November 7, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansKevin W Ng, Nikhil Faulkner, Georgina H Cornish, et al.
Nature Biotechnology|June 20, 2020
Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Nature Biotechnology|July 19, 2020
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Kidney International Reports|May 4, 2021
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against ReinfectionLuke Muir, Aneesa Jaffer, Chloe Rees-Spear, et al.
Nature Communications|October 6, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Research Square|March 24, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Science (New York, N.Y.)|November 7, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansKevin W Ng, Nikhil Faulkner, Georgina H Cornish, et al.
Nature Biotechnology|June 20, 2020
Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Nature Biotechnology|July 19, 2020
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Pageof 2